BIO-TECHNE (TECH) Income from Continuing Operations: 2009-2025
Historic Income from Continuing Operations for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $38.2 million.
- BIO-TECHNE's Income from Continuing Operations rose 13.65% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year decrease of 75.73%. This contributed to the annual value of $22.2 million for FY2025, which is 82.61% down from last year.
- BIO-TECHNE's Income from Continuing Operations amounted to $38.2 million in Q3 2025, which was up 155.48% from -$68.8 million recorded in Q2 2025.
- BIO-TECHNE's 5-year Income from Continuing Operations high stood at $89.7 million for Q3 2022, and its period low was -$68.8 million during Q2 2025.
- Over the past 3 years, BIO-TECHNE's median Income from Continuing Operations value was $34.9 million (recorded in 2024), while the average stood at $27.7 million.
- Per our database at Business Quant, BIO-TECHNE's Income from Continuing Operations surged by 563.12% in 2022 and then slumped by 16,219.44% in 2025.
- Quarterly analysis of 5 years shows BIO-TECHNE's Income from Continuing Operations stood at $72.1 million in 2021, then crashed by 30.61% to $50.0 million in 2022, then tumbled by 45.08% to $27.5 million in 2023, then climbed by 27.03% to $34.9 million in 2024, then climbed by 13.65% to $38.2 million in 2025.
- Its Income from Continuing Operations was $38.2 million in Q3 2025, compared to -$68.8 million in Q2 2025 and $22.6 million in Q1 2025.